PAI
BSX icon

Pittenger & Anderson Inc’s Boston Scientific BSX Stock Holding History

Pittenger & Anderson Inc’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-107
Closed -$6.71K – 518
2026
Q1 		$6.71K Buy
+107
New +$8.56K ﹤0.01% 423
2025
Q4 		– Sell
-4,570
Closed -$446K – 510
2025
Q3 		$446K Sell
4,570
-1,145
-20% -$119K 0.02% 194
2025
Q2 		$614K Sell
5,715
-627
-10% -$63.4K 0.02% 180
2025
Q1 		$640K Buy
6,342
+1,342
+27% +$135K 0.02% 174
2024
Q4 		$447K Hold
5,000
– – 0.02% 189
2024
Q3 		$419K Buy
+5,000
New +$394K 0.02% 192

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pittenger & Anderson Inc's BSX Position: Q2 2026 in Review

Pittenger & Anderson Inc sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 107 shares — an estimated $6.71K sold.

Pittenger & Anderson Inc first reported a position in BSX in Q3 2024 and held it in 6 quarters. The position peaked at $640K in Q1 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pittenger & Anderson Inc reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 107 Boston Scientific shares in Q2 2026, an estimated $6.71K.
  • Pittenger & Anderson Inc first reported a position in Boston Scientific in Q3 2024 and held it in 6 quarters.
  • Pittenger & Anderson Inc's Boston Scientific position peaked at $640K in Q1 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.